Clinical trial
Short Course Radical Cure of P.Vivax in Nepal- a Randomized Controlled Trial
NCT04079621 is registered in ClinicalTrials.gov with Menzies School of Health Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Short Course Radical Cure of P.Vivax in Nepal- a Randomized Controlled Trial
- Lead sponsor
- Menzies School of Health Research
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 27, 2021
- Completion date
- March 31, 2024
- Enrollment
- 27 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
malaria, malaria, vivax, malaria,falciparum